Unveiling 6 Analyst Insights On Capricor Therapeutics
Posted
Benzinga Insights (via Benzinga)
Latest Ratings for CAPR
DateFirmActionFromTo Jan 2022HC Wainwright & Co.MaintainsBuy Oct 2021HC Wainwright & Co.MaintainsBuy Jul 2019HC Wainwright & Co.MaintainsBuy
View More Analyst Ratings for CAPR
View the Latest Analyst Ratings
read more
